Arrowhead Pharmaceuticals
ARWR
#4527
Rank
NZ$2.94 B
Marketcap
$21.43
Share price
-4.20%
Change (1 day)
-54.56%
Change (1 year)

P/S ratio for Arrowhead Pharmaceuticals (ARWR)

P/S ratio as of April 2025 (TTM): 675

According to Arrowhead Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 30.1. At the end of 2024 the company had a P/S ratio of 944.

P/S ratio history for Arrowhead Pharmaceuticals from 2001 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20249445117.14%
202318.19.07%
202216.6-65.44%
202148.0-51.41%
202098.8151.89%
201939.261.22%
201824.3169.8%
20179.01-64.88%
201625.7-98.22%
2015> 10007.55%
2014> 1000-44.71%
2013> 10001936.39%
2012119-93.55%
2011> 100012700.49%
201014.439.13%
200910.3-57.95%
200824.6-72.88%
200790.6-78.6%
2006424111.8%
20052006.9%
2004187547.7%
200328.9126.56%
200212.7-11.98%
200114.5

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
15.1-97.77%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
12.2-98.19%๐Ÿ‡บ๐Ÿ‡ธ USA
262-61.21%๐Ÿ‡บ๐Ÿ‡ธ USA
4.22-99.37%๐Ÿ‡บ๐Ÿ‡ธ USA
3.33-99.51%๐Ÿ‡บ๐Ÿ‡ธ USA